To Estimate the Efficacy of Intraperitoneal Ropivacaine And Levobupivacaine block In individuals undergoing Laproscopic Surgeries.
Phase 4
- Conditions
- Health Condition 1: O- Medical and Surgical
- Registration Number
- CTRI/2024/06/069370
- Lead Sponsor
- Vaibhavi Singh
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
ASA1 AND ASA2 PATIENTS, PATIENT UNDERGOING LAPROSCOPIC SURGERIES UNDER GENERAL ANAESTHESIA, HEMODYNAMICALLY STABLE WITH ALL ROUTINE INVESTIGATION WITHIN NORMAL LIMIT, AVAILABILITY OF INFORMED CONSENT
Exclusion Criteria
Patient with ASA 3 or more, patients below 18 years and above 65 years, patient posted for emergency procedures, patient with major neurological, cardiac, respiratory, metabolic, renal, hepatic disease or with coagulation abnormality, patients with known allergies to study drug.
Study & Design
- Study Type
- PMS
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To Estimate the Efficacy of Ropivacaine And Levobupivacaine Intraperitoneal Block In Laparoscopic Surgeries as quality of analgesia provided by the drug by monitoring VAS score and vitals of the patient every hour for the next 12 hoursTimepoint: Post operatively visual assessment scoring will be done for pain, monitoring will be done 1 hourly for the next 12 hours.
- Secondary Outcome Measures
Name Time Method To determine the duration of post operative analgesia, adverse effects of drugs if any, to evaluate the complication if anyTimepoint: Post operatively visual assessment scoring will be done for pain, monitoring will be done 1 hourly for the next 12 hours.